Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.38 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.37 |
| ▸ | TUBB | P07437 | 1/20 | 0.37 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.37 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.37 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.37 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.37 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.37 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.37 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.37 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.37 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.37 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.37 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.37 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.37 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2128538 | 1.00 | CYP3A4 (0.47) | CYP3A4TNFRSF1ANFE2L2TUBB4ATUBB | |
| SCHEMBL1542243 | 0.86 | CYP3A4 (0.46) | CYP3A4NFE2L2MAPTNPC1RAB9A | |
| SCHEMBL1542246 | 0.86 | CYP3A4 (0.46) | CYP3A4NFE2L2MAPTNPC1RAB9A | |
| SCHEMBL2128560 | 0.86 | CYP3A4 (0.43) | CYP3A4NFE2L2TUBB4ATUBBTUBA3C | |
| SCHEMBL2128556 | 0.86 | CYP3A4 (0.43) | CYP3A4NFE2L2TUBB4ATUBBTUBA3C | |
| SCHEMBL1542893 | 0.84 | ERN1 (0.42) | CYP3A4NFE2L2DHODHFFAR4PTGES2 | |
| SCHEMBL12678842 | 0.83 | CYP3A4 (0.39) | CYP3A4NFE2L2TUBB4ATUBBTUBA3C | |
| SCHEMBL2129502 | 0.81 | CYP3A4 (0.38) | CYP3A4NFE2L2DHODHFFAR4PTGES2 | |
| SCHEMBL2129498 | 0.81 | CYP3A4 (0.38) | CYP3A4NFE2L2DHODHFFAR4PTGES2 | |
| SCHEMBL12678912 | 0.79 | CYP3A4 (0.36) | CYP3A4NFE2L2FFAR4KDM4EFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8273773-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2012-09-25 | — | — | US | disclosed |
| EP-2307372-B1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2012-04-25 | — | — | EP | disclosed |
| US-20100021423-A1 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100021423-A1 | Heterocyclic antiviral compounds | POLR2A, RRM2B, RRP1B | CYP3A4 528/4885TNFRSF1A 3330/4885NFE2L2 1858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.